Annexon, Inc.

NASDAQ:ANNX

Biotechnology

Healthcare
$3.52 -0.71%

-$0.04 today

Market cap
$576.73M
Beta
1.18
P/E (TTM)
-4.8
EPS (TTM)
-$1.01
52W Low $1.85High $7.18

Volume 2.98M

Average 2.56M

Balance Sheet

Inspect the capital base behind the business.

Assets

$277.57M

FY 2025 · Annual

-20.7% YoY

Liabilities

$65.92M

FY 2025 · Annual

+15.7% YoY

Equity

$211.65M

FY 2025 · Annual

-27.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents74.84M140.02M225.11M49.5M162.05M
Short-term Investments167.87M102.64M34.61M262.52M76.29M
Net Receivables00000
Inventory00000
Other Current Assets463K203K63K1.1M1.24M
Total Current Assets247.69M248.1M263.86M316.46M242.19M
Property, Plant & Equipment (Net)38.18M35.97M32.78M29.34M25.8M
Goodwill00000
Intangible Assets00000
Long-term Investments01.03M000
Tax Assets00000
Other Non-current Assets1.17M1.03M1.03M4.27M9.58M
Total Non-current Assets39.35M37M33.81M33.61M35.38M
Total Assets287.04M285.1M297.67M350.07M277.57M
Account Payables11.15M7.42M5.49M10.43M14.93M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities2.06M180K5.65M5.97M8.03M
Total Current Liabilities21.74M22.36M17.93M30.51M42.63M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities33.39M31.54M29.19M26.45M23.29M
Total Liabilities55.13M53.9M47.12M56.97M65.92M
Common Stock39K48K78K109K149K
Retained Earnings(296.32M)(438.26M)(572.5M)(710.7M)(917.39M)
Accumulated OCI(180K)(372K)(52K)10K(29K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity231.91M231.19M250.56M293.11M211.65M
Total Debt34.59M32.86M31.36M28.97M26.2M
Net Debt(40.25M)(107.16M)(193.76M)(20.53M)(135.85M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$175.2M
Short-term Investments$49.8M
Other Current$3.2M
Total Current Assets$228.3M
PP&E (Net)$24.9M
Other Non-current$9.7M
Total Non-current Assets$34.6M
Total Assets$262.9M

Analysis

Selected assets total $262.9M for Latest. The largest visible component is Cash & Equivalents at $175.2M, about 66.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 9, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
4Statement of changes in beneficial ownershipSep 25, 2026
3Initial statement of beneficial ownershipAug 12, 2026

How much cash does ANNX have?

Annexon, Inc. (ANNX) reported $162.05M in cash and equivalents in fiscal 2025.

How much debt does ANNX carry?

Annexon, Inc. (ANNX) reported $26.20M of total debt, with net debt of -$135.85M.